Recent Finacing
Recent Raise
TFF Pharmaceuticals develops inhalable dry‑powder formulations for lung diseases using a thin‑film‑freezing (TFF) platform to improve solubility and enable deep‑lung delivery of small molecules and biologics.
Focus Areas
Total Raised
Funding rounds
See the team members at TFF Pharmaceuticals.
